6-Feb-2026
Newsfile (Fri, 6-Feb 9:40 PM ET)
VistaGen Receives Nasdaq Notice on Minimum Bid Compliance
TipRanks (Fri, 6-Feb 4:32 PM ET)
Globe Newswire (Fri, 6-Feb 9:52 AM ET)
PRNewswire (Fri, 6-Feb 8:50 AM ET)
Globe Newswire (Thu, 5-Feb 5:00 PM ET)
Newsfile (Thu, 5-Feb 3:42 PM ET)
PRNewswire (Thu, 5-Feb 9:00 AM ET)
PRNewswire (Thu, 5-Feb 5:19 AM ET)
PRNewswire (Thu, 5-Feb 4:34 AM ET)
March 16, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTGN
PRNewswire (Wed, 4-Feb 2:50 PM ET)
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Vistagen Therapeutics trades on the NASDAQ stock market under the symbol VTGN.
As of February 6, 2026, VTGN stock price climbed to $0.56 with 1,720,847 million shares trading.
VTGN has a beta of 0.59, meaning it tends to be less sensitive to market movements. VTGN has a correlation of 0.00 to the broad based SPY ETF.
VTGN has a market cap of $22.24 million. This is considered a Sub-Micro Cap stock.
Last quarter Vistagen Therapeutics reported $258,000 in Revenue and -$.54 earnings per share. This fell short of revenue expectation by $-81,480 and missed earnings estimates by -$.07.
In the last 3 years, VTGN traded as high as $24.71 and as low as $.50.
The top ETF exchange traded funds that VTGN belongs to (by Net Assets): VTI, VXF, PSIL, IWC, DFAS.
VTGN has underperformed the market in the last year with a price return of -80.9% while the SPY ETF gained +15.5%. VTGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -86.5% and -15.0%, respectively, while the SPY returned +2.2% and +0.2%, respectively.
VTGN support price is $.48 and resistance is $.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VTGN shares will trade within this expected range on the day.
